Technology

Study Published in Journal of Cardiothoracic and Vascular Anesthesia Finds Accuryn Monitoring System Detects Acute Kidney Injury (AKI) in Cardiac Surgery Patients 33 Hours Earlier than Standard Serum Creatine Criteria

Published

1 year ago

January 23, 2025

Advanced monitoring technology is critical as the Centers for Medicare & Medicaid Services (CMS) will begin requiring hospitals to report all incidences of AKI as a key indicator of patient safety

Some cardiothoracic surgeons and other select specialties will also be required to participate in a CMS pilot alternative payment program designed to hold acute care hospitals responsible for the cost and care of patients who have undergone certain surgeries

HAYWARD, Calif., Jan. 23, 2025 /PRNewswire/ — A study published in the Journal of Cardiothoracic and Vascular Anesthesia, analyzes the effectiveness of the FDA-cleared Accuryn Monitoring System to monitor kidney function, reduce the risks associated with catheter-associated urinary tract infections, and streamline nurse workflow. The current study of 522 cardiac surgery patients across nine sites represents a subanalysis of the Accuryn Registry, an observational, multicenter study designed to evaluate the sensitivity, specificity, and advanced diagnosis time for acute kidney injury (AKI) provided by the Accuryn Alert system following cardiac surgery as compared to diagnosis based on routine serum creatine (SCr) measurements. The analyses demonstrate that Accuryn AKI Alerts diagnosed AKI, on average, 33 hours earlier than SCr (Stage 2 AKI).

Although not often reported, Cardiac Surgery-Associated Acute Kidney Injury is a common postoperative complication that affects approximately 40% of patients1, leading to increased mortality, extended hospital stays, and increased costs of care. Overall, approximately 42% of patients admitted to the ICU will suffer from AKI2, and it’s estimated that the extra costs associated with AKI are between $26,000 and $69,000 per patient1. AKI accounts for approximately 300,000 deaths per year3. In cardiac surgery and other postoperative patients, excessive amounts of fluids administered can lead to SCr dilution, leaving clinicians with an inaccurate assessment on the patient’s kidney function. Kidney Disease: Improving Global Outcomes (KDIGO) guidelines for AKI recommend initiating various supportive measures known as the kidney care bundle in patients at high risk in order to prevent the incidence and progression of AKI. However, this is reliant on early diagnosis of AKI.

“We’re really pleased this study of over 500 patients confirms that the Accuryn Monitoring System can help detect acute kidney injury (AKI) hours before current standard criteria,” said Sanjay Banerjee, CEO of Accuryn Medical. “Early identification is vital for clinicians to optimize treatment plans and potentially improve patient outcomes and lower healthcare costs. In addition, this technology will become even more important as recent CMS policy changes take effect, requiring hospitals to report additional data on AKI, which it classifies as reportable hospital harm.”

The Centers for Medicare & Medicaid Services (CMS) recently identified AKI as a key indicator of patient safety, and will begin requiring hospitals to report on all incidences of AKI as reportable hospital harm. CMS is also initiating a pilot alternative payment program to promote better care coordination and optimal long-term health outcomes for patients. This program, called the Transforming Episode Accountability Model (TEAM), is designed to hospitals responsible for the cost and care of patients who have undergone certain surgeries, including the first 30 days after they leave the hospital. The TEAM will affect cardiothoracic surgeons who perform coronary artery bypass grafts (CABG) and a limited number of other specialties.

The Accuryn team will be attending The 61st STS Annual Meeting on January 24-26 in Los Angeles, CA to raise awareness of cardiac surgery-associated acute kidney injury. To learn more, view the study here or visit the Accuryn team at booth #543.

About Accuryn Medical
Accuryn Medical, Inc. is committed to addressing Acute Kidney Injury (AKI) through real-time renal assessment with the Accuryn Monitoring System, which enables early intervention of AKI to reduce preventable mortality and morbidity. The platform technology provides an automated, accurate and consistent flow of data and enables a predictive algorithm for the early detection and treatment of this disease. Accuryn Medical is headquartered in Hayward, CA. For more information, visit www.accuryn.com.

Media Contact
Ken Meyer
ken@12080group.com

Scurt FG, Bose K, Mertens PR, Chatzikyrkou C, Herzog C. Cardiac Surgery–Associated Acute Kidney Injury. Kidney360 5(6):p 909-926 (June 2024). DOI: 10.34067/KID.0000000000000466James MT, Bhatt M, Pannu N, et al. Long-term outcomes of acute kidney injury and strategies for improved care. Nat Rev Nephrol 16, 193–205 (2020). DOI: 10.1038/s41581-019-0247-zKashani K, Shao M, Li G, Williams AW, Rule AD, Kremers WK, Malinchoc M, Gajic O, Lieske JC. No increase in the incidence of acute kidney injury in a population-based annual temporal trends epidemiology study. Kidney Int. 2017 Sep;92(3):721-728. doi: 10.1016/j.kint.2017.03.020

View original content:https://www.prnewswire.com/news-releases/study-published-in-journal-of-cardiothoracic-and-vascular-anesthesia-finds-accuryn-monitoring-system-detects-acute-kidney-injury-aki-in-cardiac-surgery-patients-33-hours-earlier-than-standard-serum-creatine-criteria-302358027.html

SOURCE Potrero Medical, Inc.

Technology

Equifax Announces Participation in Upcoming Investor Conferences

Published

4 minutes ago

May 1, 2026

ATLANTA, May 1, 2026 /PRNewswire/ — Equifax® (NYSE: EFX) will participate in several upcoming investor conferences in May and June.

Mark W. Begor, Chief Executive Officer, and John Gamble, Chief Financial Officer, will participate in the Baird 2026 Global Consumer, Technology & Services Conference on Tuesday, June 2, 2026 including participation in a Fireside Chat at 10:50 a.m., Eastern Time and the William Blair 2026 Growth Stock Conference on Wednesday, June 3, 2026, including participation in a Fireside Chat at 9:40 a.m., Eastern Time.

The company invites investors to join a live webcast of these Fireside Chat events at: https://investor.equifax.com/news-events/ir-calendar. A replay of these Fireside Chats will be available within 24 hours after the event on the company’s Investor Relations website.

John Gamble, Chief Financial Officer, will attend the Bernstein Annual Strategic Decisions Conference on Wednesday, May 27, 2026.

Trevor Burns, Senior Vice President of Corporate Investor Relations, will attend the Barclays Americas Select Franchise Conference on Tuesday, May 5, 2026, the virtual Needham Technology, Media, & Consumer Conference on Thursday, May 14, 2026, and the J.P. Morgan All Stars Canada Conference on Tuesday, June 2, 2026.

ABOUT EQUIFAX INC.
At Equifax (NYSE: EFX), we believe knowledge drives progress. As a global data, analytics, and technology company, we play an essential role in the global economy by helping financial institutions, companies, employers, and government agencies make critical decisions with greater confidence. Our unique blend of differentiated data, analytics, and cloud technology drives insights to power decisions to move people forward. Headquartered in Atlanta and supported by nearly 15,000 employees worldwide, Equifax operates or has investments in 24 countries in North America, Central and South America, Europe, and the Asia Pacific region. For more information, visit Equifax.com.

FOR MORE INFORMATION:
Molly Clegg for Equifax
mediainquiries@equifax.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/equifax-announces-participation-in-upcoming-investor-conferences-302760292.html

SOURCE Equifax Inc.

Technology

Cisco Schedules Conference Call for Q3 Fiscal Year 2026 Financial Results

Published

4 minutes ago

May 1, 2026

SAN JOSE, Calif., May 1, 2026 /PRNewswire/ — Cisco (NASDAQ: CSCO) has scheduled a conference call for Wednesday, May 13, 2026, at 1:30 PM (PT); 4:30 PM (ET) to announce its third quarter fiscal year 2026 financial results for the period ending Saturday, April 25, 2026.

Financial results will be released over PR Newswire via US National and European Financial distribution, after the close of the market on Wednesday, May 13, 2026. Cisco’s quarterly earnings press release will be posted at https://newsroom.cisco.com.

Date:
Wednesday, May 13, 2026

Time:
1:30 PM (PT); 4:30 PM (ET)

To Listen via Telephone:
888-848-6507
212-519-0847 (for International Callers)

To Listen via the Internet:
We are pleased to offer a live and replay audio broadcast of the conference call with corresponding slides at https://investor.cisco.com.

The conference call will also be livestreamed on YouTube & LinkedIn.

Replay:
A telephone playback of the Q3 FY2026 conference call is scheduled to be available beginning at 4:00 PM (PT) on May 13, 2026, through 10:00 PM (PT) May 19, 2026. The replay will be accessible by calling 800-839-2232 (International callers: 203-369-3662). The call runs 24 hours/day, including weekends. An archived version of the webcast will be available on Cisco’s Investor Relations website at https://investor.cisco.com.

About Cisco

Cisco (NASDAQ: CSCO) is the worldwide technology leader that is revolutionizing the way organizations connect and protect in the AI era. For more than 40 years, Cisco has securely connected the world. With its industry leading AI-powered solutions and services, Cisco enables its customers, partners and communities to unlock innovation, enhance productivity and strengthen digital resilience. With purpose at its core, Cisco remains committed to creating a more connected and inclusive future for all. Discover more on The Newsroom and follow us on X at @Cisco.

Cisco and the Cisco logo are trademarks or registered trademarks of Cisco and/or its affiliates in the U.S. and other countries. A listing of Cisco’s trademarks can be found at http://www.cisco.com/go/trademarks. Third-party trademarks mentioned are the property of their respective owners. The use of the word ‘partner’ does not imply a partnership relationship between Cisco and any other company.

Investor Relations Contact:

Press Contact:

Sami Badri

Britt Stagnaro

Cisco

sambadri@cisco.com

media_pr@external.cisco.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/cisco-schedules-conference-call-for-q3-fiscal-year-2026-financial-results-302760253.html

SOURCE Cisco Systems, Inc.

Technology

Essen Health Care Launches RADIN Health All-In-One RIS and PACS Cloud Platform

Published

4 minutes ago

May 1, 2026

SHERIDAN, Wyo. , May 1, 2026 /PRNewswire/ — Essen Health Care is thrilled to announce a significant advancement in our commitment to providing exceptional patient care and cutting-edge medical services: the introduction of RADIN Health.

This initiative represents a major investment in the future of medical imaging, solidifying our dedication to offering the highest quality diagnostic services and an unparalleled patient and provider experience within the communities we serve.

“RADIN Health is more than just a technology upgrade; it is a fundamental pillar of Essen Health Care’s strategy to deliver accessible, efficient, and superior diagnostic imaging services to our community”, says Jonathan Khodadadian, MD, Medical Director, Specialty Division, Essen Health Care.

The RADIN Platform: A Commitment to Innovation

RADIN Health is powered by an advanced, end-to-end, all-in-one RIS and PACS radiology cloud platform. This state-of-the-art system has been meticulously designed to revolutionize the imaging process, ensuring efficiency, accuracy, and accessibility for everyone involved.

Transforming the Patient and Provider Journey

The RADIN platform utilizes sophisticated, state-of-the-art artificial intelligence (AI) across multiple facets of the imaging journey:

Enhanced Patient and Provider Engagement: AI tools, patient, and referring physician portals streamline orders for appointments and communication, ensuring the external workflow process is easy, transparent, and accessible.Easy Image and Report Sharing: The cloud application allows easy electronic sharing and access of images and reports for providers and patients.Ease of Scheduling: The system simplifies the typically complex scheduling process, allowing for quick, convenient, and accurate appointment booking.Optimized Physician Reporting: AI assists in the generation of detailed, rapid, and precise physician reports, ensuring healthcare providers receive the critical information they need promptly to guide treatment decisions.

Driving Efficiency and Quality

The RADIN platform elevates the operational standards of imaging services. By reducing manual steps throughout the process—from order entry to image archival—and improving overall system efficiency, the platform ensures:

Timely Imaging Services: Quicker turnaround times mean patients receive their diagnoses faster, enabling earlier treatment planning.High-Quality Diagnostics: The system supports consistent, high-fidelity imaging quality, leading to more accurate diagnoses.Patient Follow-up Tracking: Recommended patient follow-up scans are automated and track recommendations for important, abnormal or inconclusive findings.Compliance and Best Practices: The cloud platform is built to support stringent regulatory compliance and adherence to the highest industry standards and best practices, giving both providers and patients confidence in the care received.

Essen Health Care is an integrated, multi-specialty healthcare delivery organization with more than 25 years of experience providing quality, compassionate, and accessible medical care to communities across New York. Offering house calls, urgent care, primary care, and specialty services, Essen Health Care is committed to advancing health equity and improving health outcomes for all patients. For more information, visit https://www.essenhealthcare.com

RADIN HealthⓇ is focused on developing SaaS products that enhance the efficiency, productivity, and scalability of hospitals, imaging centers and radiology practices. Utilizing artificial intelligence (AI), machine learning (ML), and natural language processing (NLP), Radin Health offers a Cloud-based, Serverless, All-In-One RIS, PACS, Dictation AI®, and Select® Workflow Management Solution. For more information, visit www.radinhealth.com.

View original content to download multimedia:https://www.prnewswire.com/news-releases/essen-health-care-launches-radin-health-all-in-one-ris-and-pacs-cloud-platform-302760463.html

SOURCE Radin LLC